Among the HBeAg-positive patients there was a numerical trend of reduced LTCs between the NA treatment (3.4%, 20/587) and no treatment (12.0%,56/468) (RR:0.24, 95%CI: 0.14-0.40; Figure 7 ).
← all excerpts
Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis.
1
—
—